Enanta Pharmaceuticals, Inc. (ENTA) financial statements (2020 and earlier)

Company profile

Business Address 500 ARSENAL STREET
WATERTOWN, MA 02472
State of Incorp. DE
Fiscal Year End September 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
TTM
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
9/30/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments37433530922421014591
Cash and cash equivalents28516466172231
Short-term investments34628424515819412360
Receivables5351671113164
Deferred tax assets   111
Other undisclosed current assets141544982
Total current assets:441402380238232171108
Noncurrent Assets
Operating lease, right-of-use asset8 
Property, plant and equipment101188862
Long-term investments and receivables41651670326441
Long-term investments41651670326441
Restricted cash and investments1111110
Other noncurrent assets000    
Deferred tax assets, net810854
Other undisclosed noncurrent assets1111     
Total noncurrent assets:70883489497547
TOTAL ASSETS:511490414327281246155
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities16231621886
Accounts payable7754322
Accrued liabilities916108543
Employee-related liabilities     21
Taxes payable  19 1 
Debt3    0 
Other undisclosed current liabilities     (2)(1)
Total current liabilities:19231621875
Noncurrent Liabilities
Long-term debt and lease obligation6    1 
Capital lease obligations   1 
Operating lease, liability6 
Liabilities, other than long-term debt2332232
Accounts payable and accrued liabilities     10
Asset retirement obligations     00
Liability for uncertainty in income taxes     0 
Other liabilities2332220
Derivative instruments and hedges, liabilities      2
Other undisclosed noncurrent liabilities22221(0)(0)
Total noncurrent liabilities:10554332
Total liabilities:2927212511107
Stockholders' equity
Stockholders' equity attributable to parent, including:482462394302270236149
Common stock0000000
Treasury stock, value      (0)
Additional paid in capital305298277256242230222
Accumulated other comprehensive income (loss)00(0)(0)00(0)
Retained earnings (accumulated deficit)17716411745286(73)
Warrants and rights outstanding     1 
Other undisclosed stockholders' equity attributable to parent     (1) 
Total stockholders' equity:482462394302270236149
TOTAL LIABILITIES AND EQUITY:511490414327281246155

Income statement (P&L) ($ in millions)

12/31/2019
TTM
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
9/30/2014
Revenues1882052071038816148
Revenue, net385836 
Cost of revenue
(Cost of Goods and Services Sold)
     (0) 
Gross profit:1882052071038816148
Operating expenses(166)(168)(118)(78)(57)(50)(39)
Other undisclosed operating income     1410
Operating income:223788253112419
Nonoperating income9952210
Investment income, nonoperating  (0)2210
Interest and debt expense   (0)(0)(0)(0)
Income from continuing operations before equity method investments, income taxes:314693273312519
Other undisclosed income from continuing operations before income taxes   0000
Income from continuing operations before income taxes:314693273312519
Income tax expense (benefit)31(21)(9)(11)(46)15
Net income available to common stockholders, diluted:34467218227934

Comprehensive Income ($ in millions)

12/31/2019
TTM
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
9/30/2014
Net income:34467218227934
Other comprehensive income (loss)  (0)(0)(0)0(0)
Comprehensive income:34467218227934
Other undisclosed comprehensive income, net of tax, attributable to parent01     
Comprehensive income, net of tax, attributable to parent:34477218227934

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: